Literature DB >> 26367205

Clinical Utilization of Repeated Open Application Test Among American Contact Dermatitis Society Members.

Gabrielle E Brown1, Nina Botto, Daniel C Butler, Jenny E Murase.   

Abstract

BACKGROUND: The repeated open application test (ROAT) provides useful information regarding allergens in suspected cases of allergic contact dermatitis; however, standardized methodology has not been established.
OBJECTIVE: The aim of this study was to assess how ROAT is used in clinical and research settings.
METHODS: We distributed a survey regarding ROAT practice to the American Contact Dermatitis Society and conducted a literature review of ROAT utilization in research.
RESULTS: A total of 67 American Contact Dermatitis Society members participated in the survey. Respondents most frequently recommend application of leave-on products twice daily (46.0%) and rinse-off products once daily (43.5%). The most commonly used anatomical sites include the forearm (38.7%) and antecubital fossa (32.3%). Most respondents continue ROAT for 1 (49.2%) or 2 weeks (31.7%). Literature review of 32 studies (26 leave-on, 6 rinse-off) revealed that application frequency is most common at twice daily for both leave-on (96.2%) and rinse-off (50.0%) products. The most common anatomical site is the forearm (62.5%), with an overall study duration of 3 to 4 weeks (65.6%).
CONCLUSIONS: When comparing ROAT clinical and research practice, the majority trend was consistent for leave-on product application frequency and anatomical site, but not for rinse-off product application frequency, or overall duration. Further research is needed to determine best practice recommendations.

Entities:  

Mesh:

Year:  2015        PMID: 26367205     DOI: 10.1097/DER.0000000000000132

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  2 in total

1.  Practical suggestions to improve standardization of repeated open application testing (ROAT) for daily use products.

Authors:  Feroze Kaliyadan; Puravoor Jayasree; Karalikkattil T Ashique
Journal:  Postepy Dermatol Alergol       Date:  2021-01-20       Impact factor: 1.664

2.  Management of Central Venous Access Device-Associated Skin Impairment: An Evidence-Based Algorithm.

Authors:  Daphne Broadhurst; Nancy Moureau; Amanda J Ullman
Journal:  J Wound Ostomy Continence Nurs       Date:  2017 May/Jun       Impact factor: 1.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.